Status:
COMPLETED
Enhancing Physical Activity in Patients With Interstitial Lung Disease
Lead Sponsor:
KU Leuven
Conditions:
Interstitial Lung Disease
Interstitial Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The level of physical activity (PA) has been shown to be an important predictor for morbidity and mortality in patients with chronic respiratory diseases such as COPD and more recently Idiopathic Pulm...
Detailed Description
The present study aims to 1\) primary objective: To explore the magnitude of the effect of a semi-automated tele coaching intervention to enhance physical activity in patients with interstitial lung ...
Eligibility Criteria
Inclusion
- Stable patients, older than 18 year, with a diagnosis of interstitial lung disease
- Understand and able to work with a smartphone application, as judged by the investigator
- On stable pharmacotherapy
- DLCO ≥30%predicted
Exclusion
- On the waiting list for a lung transplantation
- Life expectancy below 3 months
- Respiratory tract infection or an exacerbation or change in maintenance medication within 4 weeks before study enrolment
- Extra pulmonary impairments, unrelated to the underlying lung disease, interfering with physical activity
Key Trial Info
Start Date :
January 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 6 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04138173
Start Date
January 14 2020
End Date
January 6 2022
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KULeuven
Leuven, Belgium, 3000